solid-phase synthesis method fmoc (9-fluorenyl methoxycarbonyl) (LifeTein Inc)
90
Structured Review
LifeTein Inc
solid-phase synthesis method fmoc (9-fluorenyl methoxycarbonyl)
Solid Phase Synthesis Method Fmoc (9 Fluorenyl Methoxycarbonyl), supplied by LifeTein Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fmoc+solid-phase+synthesis+method/solid+phase+synthesis+method+fmoc++9+fluorenyl+methoxycarbonyl+/pm23677593-156-1-33
Average 90 stars, based on 1 article reviews
Solid Phase Synthesis Method Fmoc (9 Fluorenyl Methoxycarbonyl), supplied by LifeTein Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fmoc+solid-phase+synthesis+method/solid+phase+synthesis+method+fmoc++9+fluorenyl+methoxycarbonyl+/pm23677593-156-1-33
Average 90 stars, based on 1 article reviews
solid-phase synthesis method fmoc (9-fluorenyl methoxycarbonyl) - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Article Snippet: m ag .o rg Dysregulation of Toll-like receptor (TLR) responses to pathogens can lead to pathological inflammation or to immune hyporesponsiveness and susceptibility to infections, and may affect adaptive immune responses.. TLRs are therefore attractive therapeutic targets.. We assessed the potential of the TLR co-receptor CD14 as a target for therapeutics by investigating the magnitude of its influence on TLR responses. |